116 related articles for article (PubMed ID: 15537904)
1. Cytokine-based therapies for Crohn's disease--new paradigms.
Cominelli F
N Engl J Med; 2004 Nov; 351(20):2045-8. PubMed ID: 15537904
[No Abstract] [Full Text] [Related]
2. Anti-interleukin-12 antibody for active Crohn's disease.
Mannon PJ; Fuss IJ; Mayer L; Elson CO; Sandborn WJ; Present D; Dolin B; Goodman N; Groden C; Hornung RL; Quezado M; Yang Z; Neurath MF; Salfeld J; Veldman GM; Schwertschlag U; Strober W;
N Engl J Med; 2004 Nov; 351(20):2069-79. PubMed ID: 15537905
[TBL] [Abstract][Full Text] [Related]
3. Anti-interleukin-12 antibody for active Crohn's disease.
Orenstein R
N Engl J Med; 2005 Feb; 352(6):627-8; author reply 627-8. PubMed ID: 15703432
[No Abstract] [Full Text] [Related]
4. How deep is remission in perianal Crohn's disease and do imaging modalities matter?
Savoye G; Savoye-Collet C
Am J Gastroenterol; 2010 Jun; 105(6):1445-6; author reply 1446. PubMed ID: 20523317
[No Abstract] [Full Text] [Related]
5. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
6. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
Targan SR; Hanauer SB; van Deventer SJ; Mayer L; Present DH; Braakman T; DeWoody KL; Schaible TF; Rutgeerts PJ
N Engl J Med; 1997 Oct; 337(15):1029-35. PubMed ID: 9321530
[TBL] [Abstract][Full Text] [Related]
7. Biologic therapy in Crohn's disease.
Williams MD; Omran ML; Gordon GL
Mo Med; 2009; 106(5):356-60. PubMed ID: 19902717
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic inhibitors of tumor necrosis factor in Crohn's disease.
Ganesan S; Travis SP; Ahmad T; Jazrawi R
Curr Opin Investig Drugs; 2002 Sep; 3(9):1301-6. PubMed ID: 12498004
[TBL] [Abstract][Full Text] [Related]
9. Anti-interleukin-12 antibody for active Crohn's disease.
Kolls JK; Zhang Z
N Engl J Med; 2005 Feb; 352(6):627-8; author reply 627-8. PubMed ID: 15706644
[No Abstract] [Full Text] [Related]
10. [Biological compounds in the treatment of Crohn's disease].
Dinari G
Harefuah; 2001 Apr; 140(4):316-8. PubMed ID: 11303396
[No Abstract] [Full Text] [Related]
11. Infliximab (Remicade), a new biological treatment for Crohn's disease.
D'Haens GR
Ital J Gastroenterol Hepatol; 1999; 31(6):519-20. PubMed ID: 10575573
[TBL] [Abstract][Full Text] [Related]
12. Profile of soluble cytokine receptors in Crohn's disease.
Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
[TBL] [Abstract][Full Text] [Related]
13. Infliximab induced T lymphocyte apoptosis in Crohn's disease.
van den Brande J; Hommes DW; Peppelenbosch MP
J Rheumatol Suppl; 2005 Mar; 74():26-30. PubMed ID: 15742461
[TBL] [Abstract][Full Text] [Related]
14. Investigational agents for Crohn's disease.
Cottone M; Orlando A; Renna S
Expert Opin Investig Drugs; 2010 Oct; 19(10):1147-59. PubMed ID: 20836616
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF treatment in Crohn's disease: toward tailored therapy?
D'Haens G
Am J Gastroenterol; 2010 May; 105(5):1140-1. PubMed ID: 20445512
[TBL] [Abstract][Full Text] [Related]
16. Managing complicated Crohn's disease in children and adolescents.
Homan M; Baldassano RN; Mamula P
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):572-9. PubMed ID: 16327836
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
18. Treatment of vulval Crohn's disease with infliximab.
Preston PW; Hudson N; Lewis FM
Clin Exp Dermatol; 2006 May; 31(3):378-80. PubMed ID: 16681581
[TBL] [Abstract][Full Text] [Related]
19. Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha.
Nos P; Bastida G; Beltran B; Aguas M; Ponce J
Am J Gastroenterol; 2006 Sep; 101(9):2165-6. PubMed ID: 16968516
[No Abstract] [Full Text] [Related]
20. [Anti-TNF therapy and Crohn's disease].
Peyrin-Biroulet L
Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):478-81. PubMed ID: 18439777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
